Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Microscopy, Electron × Clear all
NCT00909831 2019-04-16

Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00714181 2016-02-18

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
38 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡